1. Targeting the TGFβ pathway for cancer therapy
   Cindy Neuzillet et al, 2015, Pharmacology & Therapeutics CrossRef
2. Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease
   Fabiane L. de Oliveira et al, 2012, PLoS Negl Trop Dis CrossRef
3. TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies
   Tristan Courau et al, 2016 CrossRef
4. Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors
   Yiran Zheng et al, 2017, ACS Nano CrossRef
5. Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks.
   Jingyu Zhang et al, 2016, J Clin Med CrossRef
6. Targeting Transforming Growth Factor-<i>β</i> (TGF-<i>β</i>) in Cancer and Non-Neoplastic Diseases
   Michael Nacif et al, 2014, JCT CrossRef
7. Barriers to Radiation-Induced In Situ Tumor Vaccination
   Erik Wennerberg et al, 2017, Front. Immunol. CrossRef
8. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.
   Bhagelu Ram Achyut et al, 2011, Gastroenterology CrossRef
9. Targeting TGF-β signaling in cancer
   Lior H Katz et al, 2013, Expert Opinion on Therapeutic Targets CrossRef
10. Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model
    Misako Sato et al, 2015, PLoS ONE CrossRef
11. Transforming growth factor-β: A therapeutic target for cancer.
    Sulsal Haque et al, 2017, Hum Vaccin Immunother CrossRef
12. Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus
    HAN-XIAN GONG et al, 2012 CrossRef
13. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases
    Benjamin Frey et al, 2017, Immunol Rev CrossRef
14. Involvement of the TGFβ1/Smad2/MMP3 signaling pathway in SB431542-induced inhibition of cell invasion in multiple myeloma RPMI 8226 cells
    Huang Xi et al, 2017 CrossRef
15. TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
    Laia Caja et al, 2018, IJMS CrossRef
16. Activin Receptor‐Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy
    Qian Wang et al, 2018, J Am Heart Assoc CrossRef
17. TGF-ß and Tyrosine Kinases: Context in Colorectal Cancer
    Siva K. P. Konduru et al, 2018 CrossRef
18. Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model
    Huiqiang Zhao et al, 2018, Human Gene Therapy CrossRef
19. Current status and future prospects of transforming growth factor-β as a potential prognostic and therapeutic target in the treatment of breast cancer
    Forouzan Amerizadeh et al, 2019, J Cell Biochem CrossRef
20. Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
    Suzanne Ostrand-Rosenberg et al, 2019, Front. Oncol. CrossRef
21. Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis
    Bozena Kaminska et al, 2020 CrossRef
22. Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage
    Hao Wang et al, 2020, European Journal of Medicinal Chemistry CrossRef
23. The Promise of Combining Radiation Therapy With Immunotherapy
    Justin C. Jagodinsky et al, 2020, International Journal of Radiation Oncology*Biology*Physics CrossRef
24. Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies.
    Shihori Tanabe et al, 2020, Front Pharmacol CrossRef
25. Direct effects of transforming growth factor-β1 signaling on the differentiation fate of fetal hepatic progenitor cells
    Aimaiti Yasen et al, 2020, Regenerative Medicine CrossRef
26. TGF-β signaling regulates SPOP expression and promotes prostate cancer cell stemness
    Chenchen Jiao et al, 2020, Aging CrossRef
27. EW-7197, a Novel ALK-5 Kinase Inhibitor, Potently Inhibits Breast to Lung Metastasis
    Ji Yeon Son et al, 2014, Mol Cancer Ther CrossRef
28. Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
    Tiina E. Kähkönen et al, 2021, Cells CrossRef
29. A novel prodrug and its nanoformulation suppress cancer stem cells by inducing immunogenic cell death and inhibiting indoleamine 2, 3-dioxygenase
    Jiankun Guan et al, 2021, Biomaterials CrossRef
30. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers
    Xiaoqun Lv et al, 2021, WJGO CrossRef
31. Discovery of TGFBR1 (ALK5) as a potential drug target of quercetin glycoside derivatives (QGDs) by reverse molecular docking and molecular dynamics simulation
    Jiahui Xu et al, 2021, Biophysical Chemistry CrossRef
32. Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
    Steven David et al, 2022, Biomedicines CrossRef
33. Asthma Promotes Choroidal Neovascularization via the Transforming Growth Factor Beta1/Smad Signalling Pathway in a Mouse Model
    Fei Yang et al, 2022, Ophthalmic Res CrossRef
34. Extracellular matrix and its therapeutic potential for cancer treatment.
    Jiacheng Huang et al, 2021, Signal Transduct Target Ther CrossRef
35. Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics
    Kassandra M. Coyle et al, 2023, Cancers CrossRef
36. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis
    Shengxin Huang et al, 2023, Acta Biomaterialia CrossRef
37. Ral GTPase promotes metastasis of pancreatic ductal adenocarcinoma via elevation of TGF-β1 production
    Mingxin Cao et al, 2023, Journal of Biological Chemistry CrossRef
38. TGF-β Signaling in Progression of Oral Cancer
    Yuanyuan Guo et al, 2023, IJMS CrossRef
39. TGF-β signaling in health, disease, and therapeutics.
    Ziqin Deng et al, 2024, Signal Transduct Target Ther CrossRef
40. Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
    Nour Arakil et al, 2024, Biomedicines CrossRef
41. Effects of Chemical Factors in the Tumor Microenvironment on the Biophysical Properties and Immune Function of Dendritic Cells
    Zuquan Hu et al, 2024 CrossRef